K
Kitty S. C. Fung
Researcher at United Christian Hospital
Publications - 84
Citations - 5722
Kitty S. C. Fung is an academic researcher from United Christian Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 27, co-authored 77 publications receiving 3800 citations. Previous affiliations of Kitty S. C. Fung include The Chinese University of Hong Kong.
Papers
More filters
Journal ArticleDOI
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.
Ivan Hung,Kwok Cheung Lung,Eugene Yuk Keung Tso,Raymond W. Liu,Tom Wai-Hin Chung,Man Yee Chu,Yuk Yung Ng,Jenny Lo,Jacky Chan,Anthony Raymond Tam,Hoi-Ping Shum,Veronica L. Chan,Alan Ka Lun Wu,Kit Man Sin,Wai Shing Leung,Wai Lam Law,David Christopher Lung,Simon Yung Wa Sin,Pauline Yeung,Cyril C. Y. Yip,Ricky Ruiqi Zhang,Agnes Yim Fong Fung,Erica Yuen Wing Yan,Kit-Hang Leung,Jonathan Daniel Ip,Allen Wing-Ho Chu,Wan Mui Chan,Anthony Chin-Ki Ng,Rodney A. Lee,Kitty S. C. Fung,Alwin Wt Yeung,Tak Chiu Wu,Johnny W.M. Chan,Wing Wah Yan,Wai-Ming Chan,Jasper Fuk-Woo Chan,Albert K. W. Lie,Owen Tak Yin Tsang,Vincent C.C. Cheng,Tak-Lun Que,Chak Sing Lau,Kwok-Hung Chan,Kelvin K. W. To,Kwok-Yung Yuen +43 more
TL;DR: Yu et al. as mentioned in this paper assessed the efficacy and safety of combined interferon beta-1b, lopinavir-ritonavir, and ribavirin for treating patients with COVID-19.
Journal ArticleDOI
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
Tao Zuo,Fen Zhang,Grace Lui,Yun Kit Yeoh,Amy Li,Hui Zhan,Yating Wan,Arthur C.K. Chung,Chun Pan Cheung,Nan Chen,Christopher K C Lai,Zigui Chen,Eugene Y.K. Tso,Kitty S. C. Fung,Veronica L. Chan,Lowell Ling,Gavin M. Joynt,David S.C. Hui,Francis K.L. Chan,Paul K.S. Chan,Siew C. Ng +20 more
TL;DR: Fecal microbiota alterations were associated with fecal levels of SARS-CoV-2 and COVID-19 severity, and strategies to alter the intestinal microbiota might reduce disease severity.
Journal ArticleDOI
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.
Yun Kit Yeoh,Tao Zuo,Grace Lui,Fen Zhang,Qin Liu,Amy Li,Arthur C.K. Chung,Chun Pan Cheung,Eugene Y.K. Tso,Kitty S. C. Fung,Veronica L. Chan,Lowell Ling,Gavin M. Joynt,David S.C. Hui,Kai Ming Chow,Susanna So Shan Ng,Timothy Li,Rita W Y Ng,Terry Cheuk-Fung Yip,Grace Lai-Hung Wong,Francis K.L. Chan,Chun K. Wong,Paul K.S. Chan,Siew C. Ng +23 more
TL;DR: In this article, the authors investigated whether the gut microbiome is linked to disease severity in patients with COVID-19, and whether perturbations in microbiome composition, if any, resolve with clearance of the SARS-CoV-2 virus.
Journal ArticleDOI
Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong
Tracy H T Lai,Tracy H T Lai,Emily W H Tang,Emily W H Tang,Sandy K. Y. Chau,Kitty S. C. Fung,Kenneth K. W. Li,Kenneth K. W. Li +7 more
TL;DR: Local experience of stepping up infection control measures for COVID-19 infection in ophthalmology can help ophthalmologists globally to prepare for the potential community outbreak or pandemic.
Journal ArticleDOI
SARS transmission among hospital workers in Hong Kong.
Joseph Lau,Kitty S. C. Fung,Tze Wai Wong,Jean H. Kim,Eric Wong,S.C.Sydney Chung,Deborah Ho,Louis Yik-Si Chan,S.F. Lui,Augustine F. B. Cheng +9 more
TL;DR: The likelihood of SARS infection was strongly associated with the amount of personal protection equipment perceived to be inadequate, having <2 hours of infection control training, and not understanding infection control procedures.